Ask AI
ProCE Banner Activity

Takeaways From a Large Educational Program on Available and Emerging Treatment Options for HER2-Positive mBC

Podcast Episodes

Audio podcast with expert insights and takeaways from a large educational program on available and emerging first-line treatment options for HER2-positive metastatic breast cancer. 

Released: July 25, 2025

Expiration: January 24, 2026

Share

Provided by

Provided by Clinical Care Options, LLC. in partnership with Smart Patients

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Smart Patients

ProCE Banner

Disclosure

Primary Author

Shipra Gandhi, MD, MS: consultant/advisor/speaker: AstraZeneca, Hologic, Novartis, Roche.

Laura Spring, MD: consultant/advisor/speaker: AstraZeneca, Daiichi Sankyo, Lilly, Novartis, Precede, Seagen; researcher: AstraZeneca, Genentech, Gilead, Lilly, Merck; other (travel support): Lilly.